Zydus Cadila receives US FDA approval for simvastatin (PharmaBiz)
Cadila Healthcare Ltd has launched Simvastatin tablets 5 mg, 10 mg, 20 mg, 40 mg and 80 mg, in the US market on the very first day of receiving the approvals from the US FDA.

Memory Pharmaceuticals Announces Release Of Clinical Hold On MEM 3454 (Medical News Today)
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the investigational new drug application (IND) for MEM 3454 and has informed the Company that the clinical hold on the development of this drug candidate has been released. [click link for full article]

Pivotal Submission Data Shows Tasigna(R) Achieved Impressive Response Rates In Chronic Myeloid Leukemia Patients No ... (Medical News Today)
New clinical data presented today demonstrated that Tasigna(R) (nilotinib) eliminated or significantly reduced the presence of blood cells containing a defective chromosome in approximately half of adult patients with a form of life-threatening leukemia who developed resistance and/or intolerance to treatment with Gleevec(R) (imatinib mesylate) tablets. [click link for full article]